ロード中...
Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details
PURPOSE: Intermittent androgen deprivation (IAD) has been widely tested in prostate cancer. However, phase III trials testing continuous androgen deprivation (CAD) versus IAD have reached inconclusive and seemingly contradictory results. Different design and conduct issues must be critically evaluat...
保存先:
| 出版年: | J Clin Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5242560/ https://ncbi.nlm.nih.gov/pubmed/26552421 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.8065 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|